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The retirement age of the baby boom generation is almost out-door. The proportion of ageing people 
will grow rapidly in the near future [1-3]. There will be fewer people to pay for the health and social 
care of the quickly aging population; furthermore, advancements in medical science will raise a new 
bar for quality in terms of the outcomes achieved in the treatment of illness [3]. An ageing population 
and the rising public expectations will produce an increase in costs and will impede timely access to 
care, thus jeopardising sustainability. 
The Italian National Health system is an example of a collapsing system: the ageing Italian workforce af-
fects not only patient demographics but also the availability of clinicians. The upcoming wave of retiring 
health care professionals will occur in the exact moment when they will be more necessary. To overcome 
these challenges, our health care system will have to use its resources more effectively. Access and equity 
remain essential characteristics of our health care system, but are insufficient goals in terms of impro-
ving quality and achieving financial sustainability. Decades of reforms have not solved the problem, and 
current solutions, such as strict cost controls, empowering consumers, or betting on internet technology 
represent simplistic solutions. This fact creates an inefficient monopoly with irresistible pressures to 
exert bargaining power, limits services, and attempts to micromanage care delivery. It will only make 
things getting worse by exacerbating the zero-sum competition present in the current system [4]. 
The present point of view considers the treatments and the health service performances as the main 
aim and the final product of an efficient national health system. This is the price of common wishful 
thinking about our health care service performances. The belief that treatments are always effective, 
and that prevention always works is profoundly seductive to patients, who wish to benefit; to physi-
cians, who want to be helpful; to politicians, who want the health service to be cost effective; and to the 
whole medical industrial complex, whose technologies and pharmaceuticals drive enormous profits 
[5]. An example of this overoptimistic point of view is stroke medicine, where the benefits of treat-
ment are exaggerated and wishful thinking often trumps the published evidence. The Royal College of 
Physicians’ press release that accompanied its 2010 stroke audit report in England is a recent pertinent 
example [6]. The concentration on the hyper-acute care [7] along with wishful thinking [6] are having 
and have had a high price in stroke medicine, without a true everyday clinical benefit [8,9]. The futility 
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of this approach is due to a fragmented intervention instead of an integrated approach. Clinical care 
delivery models differ between different diseases. Effective care processes will reflect the predispo-
sing factors, the cause (aetiology), course and consequences of a particular disease, and the available 
therapy options and their costs. Depending on the nature of the disease, care may be delivered most 
appropriately in primary, emergency or palliative care settings; it may be focused to different extents 
on prevention, management, or cure; and it may be characterised by remission states with flare-ups 
(Figure 1). 
Value for the patient involves the full cycle of care, not just the outcome of a single intervention. The 
“good” or product is health, not treatment. Better health is inherently less expensive than poor health 
and a higher quality care is often less costly than a low quality one. It was assumed that the quality of 
health care was good enough, and seen the problem as cost. However, obtaining a better health status 
is different from buying a car, where a sporting car is inherently more costly than a city car. Further-
more, the experience of the last decades has shown that the more the focus is on driving down costs, 
the more costs tend to increase. This is because the efforts to control costs often degenerate to cost shift-
ing and eliminating discretionary, but this monitoring services-based approach has introduced only 
major inefficiencies in the system. In the long run, when the interventions on the health status of a 
population should be evaluated, the value of these interventions is obviously eroded. 
The best way to reduce costs is to drive improvements in quality, but a true quality as measured by 
results. There is consistent evidence that better quality care leads to an improved efficiency. So, perhaps 
more than in any other sectors, better quality inherently reduces costs. Prevention and disease man-
agement cost less than acute treatment and rehabilitation. Treatment earlier in the causal chain is less 
costly. Getting the diagnosis right is more efficient than failed or unnecessary treatment. Fewer mis-
takes and complications cost less. Less invasive treatments enable less expensive recovery. Getting the 
right form of treatment to the right patients reduces the costs of failed or ineffective therapies. Faster 
recovery is less expensive than convalescence. Less disability means less long-term care. 
At the present point, the system must be restructured to radically improve its value. Otherwise, increas-
ing amounts of rationing and administrative control of health care are inevitable. The only way to truly 
reform the health care system is a value-based competition on results, which is defined as the health 
outcomes achieved per Euro spent [4]. In synthesis, the goal is to increase value and not just contain 
costs. Value is measured by the overall health outcome achieved relative to the total costs of care over 
Figure 1. Continuum of health care delivery. Figure shows the main types of health care delivery 
settings. These are not mutually exclusive. For example, care for stroke spans several settings – 
emergency, acute and post-acute. The organisation and delivery of health care services are complex 
concepts that are challenging to define. The delivery system includes a variety of personnel, 
processes and infrastructure elements
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the full cycle of the patient’s illnesses. Value-based health care delivery seeks to minimise the overall 
costs of care, not just focus on minimising the cost of individual services or interventions. Value-based 
care delivery spends more on appropriate services in order to save through early intervention, reducing 
mistakes, minimising complications, and forestalling disease recurrences. 
However, to achieve this goal, the physician’s understanding of this process must be changed. Needs 
for health care are determined by the patient’s medical condition. Care for a medical condition must 
integrate not only the activities directly related to the disease, but also to the related conditions, and 
defined for patient groups with similar needs [10]. From this point of view, patient populations re-
quiring different bundles of primary and preventive care services might include, for example, healthy 
children, healthy adults, patients with a single chronic disease, frail elderly people, and patients with 
multiple chronic conditions. Each patient group has unique needs and requires inherently different 
primary care services which are best delivered by different teams, and potentially in different settings 
and facilities. Care for a medical condition usually involves multiple specialties and numerous inter-
ventions. Value for the patient is created not by each intervention or specialty, but by the combined 
efforts of all of them. Patient outcomes will depend on a sequence of interventions often involving dif-
ferent sites and types of care — outpatient care, inpatient care, office visits, tests, rehabilitation, counsel-
ling, medications, procedures, and so on. The benefits of each intervention for ultimate outcomes will 
depend on the effectiveness of other interventions throughout the care cycle. Because care activities 
are interdependent, value for patients is often revealed only over time and manifested in longer-term 
outcomes such as sustainable recovery, need for ongoing interventions, or occurrences of treatment-
induced illnesses. The only way to accurately measure the value of an effective health intervention is to 
track individual patient outcomes and costs longitudinally over the full care cycle.
This is the integrated point of view of Review in Health Care: showing the future avenues in health care 
and suggesting how they can help in changing the health care. This mission is fundamental for a Jour-
nal as RHC which has the high-flying mission of improving the health care quality because, quoting 
Adam Smith: «We trust our health to the physician [...]. Such confidence could not safely be reposed 
in people of a very mean or low condition. Their reward must be such, therefore, as may give them that 
rank in the society which so important a trust requires. The long time and great expense which must 
be laid out in their education, when combined with this circumstance, necessarily enhance still further 
the price of their labour». We want to create a system that encourages innovation and drives towards 
excellence and efficiency over time.
Let’s get started!
References
Rogerson PA, Kim D. Population distribution and redistribution of the baby-boom cohort in the 1. 
United States: recent trends and implications. Proc Natl Acad Sci USA 2005; 102: 15319-24
Parker MG, Thorslund M. Health trends in the elderly population: getting better and getting wor-2. 
se. Gerontologist 2007; 47: 150-8
Smith K, Toder E, Iams H. Lifetime distributional effects of Social Security retirement benefits. 3. Soc 
Secur Bull 2003; 65: 33-61
Porter ME. What is value in health care? 4. N Engl J Med 2010; 363: 2477-81
Heath I. The price of wishful thinking. 5. BMJ 2010; 341
Royal College of Physicians. Better community care needed to help stroke victims recover. Perss 6. 
release, 19 August 2010
Fisher M. Developing and implementing future stroke therapies: the potential of telemedicine. 7. 
Ann Neurol 2005; 58: 666-71
6 Reviews in Health Care 2011; 2(1) © SEEd Tutti i diritti riservati
Editorial M. Di Napoli
Price CI, Clement F, Gray J, Donaldson C, Ford GA. Systematic review of stroke thrombolysis 8. 
service configuration. Expert Rev Neurother 2009; 9: 211-33
National Institute for Health and Clinical Excellence. NICE cost impact and commissioning 9. 
assessment: quality standard for stroke. NICE, 2010. Available at: http://www.nice.org.uk/
media/87D/33/StrokeCostingCommissioningAssessment.pdf 
Krumholz HM, Keenan PS, Brush JE Jr, Bufalino VJ, Chernew ME, Epstein AJ, et al; American 10. 
Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; Ameri-
can College of Cardiology Foundation. Standards for measures used for public reporting of effi-
ciency in health care: a scientific statement from the American Heart Association Interdisciplina-
ry Council on Quality of Care and Outcomes research and the American College of Cardiology 
Foundation. J Am Coll Cardiol 2008; 52: 1518-26
Featured in this Issues
The intracerebral haemorrhage associated to oral anticoagulant therapy: the practical 
management of urgent reversal therapy
Medical area • . Internal medicine, emergency medicine, cardiology, geriatrics, neurology, neurosur-
gery, neuroradiology, haemostasis and thrombosis.
Why is a review on this topic needed?  • The great diffusion of oral anticoagulant therapy (OAT), 
especially in elderly patients, and the consequent major haemorrhages, often fatal, makes this re-
view of the literature essential to widespread the indications for the correct management of the 
urgent OAT reversal. In particularly, this review highlights the drugs currently available in Italy, 
their advantages and disadvantages, their correct usage and controindications.
Key message.  • Strategies for urgent oral anticoagulant therapy reversal remain underused but they 
are safe and efficacious and could reduce mortality of OAT related intracerebral haemorrhage.
Smoking cessation interventions in nurses and other health care workers
Medical area.  • Public health and prevention.
Why is a review on this topic needed?  • Tobacco smoking is the leading preventable cause of the 
most important diseases and the treatment of tobacco-related diseases makes up an economic bur-
den to the health care system as well as to society. Health care professionals have an important role 
to play both as advisers, influencing smoking cessation, and as role models.
Key message.  • There is evidence that smoking cessation interventions among health care workers 
can be effective. This is of particular interest both for reducing tobacco smoking prevalence among 
this type of workers and for helping them to be useful model for the general population.
Chronic obstructive pulmonary disease and comorbidity: possible implications in the 
disease management
Medical area.  • Internal medicine, geriatrics, cardiology, general medicine, respiratory medicine.
Why is a review on this topic needed?  • Chronic obstructive pulmonary disease (COPD) is beco-
ming the first cause of pulmonary disability and death. Because of the increase in the mean age of 
the population, COPD is frequently associated with important comorbidities that require medical 
attention.
Key message.  • An interdisciplinary co-operation between all the clinicians involved in the manage-
ment of the disease could be useful in promoting specific strategies able to affect the several pulmo-
nary and extra-pulmonary components of the disease. New pharmacologic options active on both 
pulmonary and extra-pulmonary inflammation might be useful in the future.
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Perioperative intensive care in patients with brain tumours
Medical area.  • Neurosurgery, neurology, intensive care.
Why is a review on this topic needed?  • The surgery of brain tumours is not free from complica-
tions. Preoperative evaluation aims at minimising the risks; nevertheless this evaluation has not yet 
been defined and is not based on a strong evidence.
Key message.  • Neuroimaging techniques and the progresses of microsurgery, neuromonitoring and 
dedicated intensive care units contributed in recent years to improving the results of neurosurgery. 
Perioperative multidisciplinary management is essential in improving the outcomes.
